Liu L - Search Results

1

High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study.

Zhao L, Li T, Song Y, Yang Y, Ma B, Zhang Y, Shang Y, Xu B, Guo J, Qin P, Han L, Fu X, Lin H, Liu L, Ren X, Wang Z, Gao Q. Zhao L, et al. Among authors: liu l. Front Immunol. 2022 Jan 4;12:779248. doi: 10.3389/fimmu.2021.779248. eCollection 2021. Front Immunol. 2022. PMID: 35058923 Free PMC article. Clinical Trial.

2

Fibroblast activation protein: A potential therapeutic target in cancer.

Liu R, Li H, Liu L, Yu J, Ren X. Liu R, et al. Among authors: liu l. Cancer Biol Ther. 2012 Feb 1;13(3):123-9. doi: 10.4161/cbt.13.3.18696. Epub 2012 Feb 1. Cancer Biol Ther. 2012. PMID: 22236832 Free article. Review.

3

Randomized study of autologous cytokine-induced killer cell immunotherapy in metastatic renal carcinoma.

Liu L, Zhang W, Qi X, Li H, Yu J, Wei S, Hao X, Ren X. Liu L, et al. Clin Cancer Res. 2012 Mar 15;18(6):1751-9. doi: 10.1158/1078-0432.CCR-11-2442. Epub 2012 Jan 24. Clin Cancer Res. 2012. PMID: 22275504 Clinical Trial.

4

Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study.

Li R, Wang C, Liu L, Du C, Cao S, Yu J, Wang SE, Hao X, Ren X, Li H. Li R, et al. Among authors: liu l. Cancer Immunol Immunother. 2012 Nov;61(11):2125-33. doi: 10.1007/s00262-012-1260-2. Epub 2012 May 13. Cancer Immunol Immunother. 2012. PMID: 22581306 Free PMC article. Clinical Trial.

5

MiR-205 in cancer: an angel or a devil?

Qin AY, Zhang XW, Liu L, Yu JP, Li H, Wang SZ, Ren XB, Cao S. Qin AY, et al. Among authors: liu l. Eur J Cell Biol. 2013 Feb;92(2):54-60. doi: 10.1016/j.ejcb.2012.11.002. Epub 2012 Dec 29. Eur J Cell Biol. 2013. PMID: 23279926 Review.

6

Clinical implication of microrna for lung cancer.

Wang Y, Zhang X, Liu L, Li H, Yu J, Wang C, Ren X. Wang Y, et al. Among authors: liu l. Cancer Biother Radiopharm. 2013 May;28(4):261-7. doi: 10.1089/cbr.2012.1401. Epub 2013 Mar 15. Cancer Biother Radiopharm. 2013. PMID: 23496233 Review.

7

Immunotherapy with cytokine-induced killer cells as an adjuvant treatment for advanced gastric carcinoma: a retrospective study of 165 patients.

Zhao H, Fan Y, Li H, Yu J, Liu L, Cao S, Ren B, Yan F, Ren X. Zhao H, et al. Among authors: liu l. Cancer Biother Radiopharm. 2013 May;28(4):303-9. doi: 10.1089/cbr.2012.1306. Epub 2013 Mar 18. Cancer Biother Radiopharm. 2013. PMID: 23506427

8

A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocellular carcinoma.

Yu X, Zhao H, Liu L, Cao S, Ren B, Zhang N, An X, Yu J, Li H, Ren X. Yu X, et al. Among authors: liu l. J Clin Immunol. 2014 Feb;34(2):194-203. doi: 10.1007/s10875-013-9976-0. Epub 2013 Dec 15. J Clin Immunol. 2014. PMID: 24337625 Clinical Trial.

9

Cytokine-induced killer cell therapy for the treatment of primary hepatocellular carcinoma subsequent to liver transplantation: A case report.

Li R, Yan F, Liu L, Li H, Ren B, Hui Z, Ren X. Li R, et al. Among authors: liu l. Oncol Lett. 2016 Mar;11(3):1885-1888. doi: 10.3892/ol.2016.4109. Epub 2016 Jan 14. Oncol Lett. 2016. PMID: 26998094 Free PMC article.

10

Indoleamine 2,3-dioxygenase regulates T cell activity through Vav1/Rac pathway.

Li R, Li H, Sun Q, Liu L, Zhang C, Ren X. Li R, et al. Among authors: liu l. Mol Immunol. 2017 Jan;81:102-107. doi: 10.1016/j.molimm.2016.11.018. Epub 2016 Dec 5. Mol Immunol. 2017. PMID: 27930920

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74,214 results

Search Page

Filters